了解早期发病的阿尔茨海默氏病的发展
Percy Griffin1, Liana Apostolova2, Bradford C Dickerson3
1Alzheimer's Association, Medical & Scientific Relations, Chicago, Illinois, USA.
概括
早期发病的阿尔茨海默氏症 (EOAD) 影响65岁以下的人,带来独特的挑战. 纵向早期阿尔茨海默病研究 (LEADS) 解决了这一差距,通过招募和跟踪患者来推进研究和支持.
科学领域:
- 神经学 神经学
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 阿尔茨海默病 (AD) 诊断在任何年龄都具有破坏性.
- 早期发病的阿尔茨海默病 (EOAD),在65岁之前出现症状,对那些处于最佳状态的人来说带来了独特的挑战.
- 由于不典型的发病年龄,EOAD患者经常被排除在研究之外.
研究的目的:
- 为弥补早期阿尔茨海默病的研究差距.
- 为患者,家属和护理人员提供有关 EOAD 研究,治疗和支持的信息.
- 为了在第一个以EOAD为重点的会议上促进讨论和信息共享.
主要方法:
- 纵向早期阿尔茨海默病研究 (LEADS) 于2018年建立.
- LEADS旨在在美国15多个地区招募和跟踪500名EOAD个人.
- 2021年9月,为EOAD患者,家属和护理人员举行了一次会议.
主要成果:
- 2021年9月的会议通知了超过217名注册人.
- 会议涵盖了EOAD生物学,新兴治疗方法,法律/财务规划和支持网络.
- LEADS正在积极招募和跟踪参与者,以收集关键数据.
结论:
- 对早期阿尔茨海默病的专门研究和支持非常需要.
- 该LEADS研究和相关会议对于促进对EOAD的理解和关怀至关重要.
- 对EOAD的持续关注对于解决这种患者群体的独特需求至关重要.
相关概念视频
01:26Alzheimer's Disease: Overview
527
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
527
01:22Alzheimer's Disease: Treatment
220
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
220
01:30Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141
01:15Parkinson's Disease: Overview
606
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
606
01:29Biological Causes of Schizophrenia
103
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
103